Patent · US Active

Benzoimidazole indolyl methanes and methods of using them to inhibit PCKS9 and PCKS9-mediated ailments

US11427569B2 · kind B2 · utility

0Cited by

1References

11Claims

0Family size

Assignee

Wisconsin Alumni Research Foundation · US

Inventors

Weiping Tang · Nanhu, CN
Gabrielle N. Winston-McPherson · Seattle, US
Haibo Xie · King of Prussia, US
Alan Attie · Madison, US
Mark Keller · McFarland, US
Ka Yang · Madison, US

Key dates

Filing date	Feb 13, 2020
Grant date	Aug 30, 2022
Priority date	—
Expiry date	Jun 26, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/05
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Described are benzoimidazole indolyl methane compounds, pharmaceutical compositions containing them, and use of the compounds to inhibit PCSK9-mediated ailments. The compounds have the structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.